These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35426442)

  • 61. Prevalence and incidence of generalized pustular psoriasis in Sweden: a population-based register study.
    Löfvendahl S; Norlin JM; Schmitt-Egenolf M
    Br J Dermatol; 2022 Jun; 186(6):970-976. PubMed ID: 34978071
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Increased level of high mobility group box 1 in the serum and skin in patients with generalized pustular psoriasis.
    Watanabe T; Yamaguchi Y; Watanabe Y; Takamura N; Aihara M
    J Dermatol; 2020 Sep; 47(9):1033-1036. PubMed ID: 32613742
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A newly revealed IL36RN mutation in sibling cases complements our IL36RN mutation statistics for generalized pustular psoriasis.
    Takeichi T; Togawa Y; Okuno Y; Taniguchi R; Kono M; Matsue H; Sugiura K; Akiyama M
    J Dermatol Sci; 2017 Jan; 85(1):58-60. PubMed ID: 27802907
    [No Abstract]   [Full Text] [Related]  

  • 64. Novel IL36RN Mutation Identified in Pediatric-Onset Generalized Pustular Psoriasis Causes IL36 Antagonist Degradation.
    Li H; Liao D; Meng S; Liu J; Li S; Ni S; Xu Y; Zhao Y; Zhou W
    J Clin Immunol; 2021 Apr; 41(3):701-704. PubMed ID: 33415665
    [No Abstract]   [Full Text] [Related]  

  • 65. [Dermatology: re-defining psoriasis].
    Cortes B; Boehncke WH
    Rev Med Suisse; 2015 Jan; 11(456-457):49-52. PubMed ID: 25799650
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Autoinflammatory diseases in dermatology: DITRA and CAMPS].
    Sugiura K
    Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(3):169-173. PubMed ID: 28747603
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Successful therapy with anakinra in a patient with generalized pustular psoriasis carrying IL36RN mutations.
    Hüffmeier U; Wätzold M; Mohr J; Schön MP; Mössner R
    Br J Dermatol; 2014 Jan; 170(1):202-4. PubMed ID: 23909475
    [No Abstract]   [Full Text] [Related]  

  • 68. Toll-like receptor 4 antagonist TAK-242 inhibits autoinflammatory symptoms in DITRA.
    Shibata A; Sugiura K; Furuta Y; Mukumoto Y; Kaminuma O; Akiyama M
    J Autoimmun; 2017 Jun; 80():28-38. PubMed ID: 28196704
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A novel IL36RN/IL1F5 homozygous nonsense mutation, p.Arg10X, in a Japanese patient with adult-onset generalized pustular psoriasis.
    Sugiura K; Takeichi T; Kono M; Ogawa Y; Shimoyama Y; Muro Y; Akiyama M
    Br J Dermatol; 2012 Sep; 167(3):699-701. PubMed ID: 22428995
    [No Abstract]   [Full Text] [Related]  

  • 70. Deficiency of interleukin-36 receptor antagonist (DITRA): An analysis of 58 Chinese patients in a tertiary hospital in Taiwan.
    Hsieh CY; Huang YW; Huang YH; Tsai TF
    Exp Dermatol; 2023 Aug; 32(8):1272-1278. PubMed ID: 36843341
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Clinical background of patients with psoriasiform skin lesions due to tumor necrosis factor antagonist administration at a single center.
    Mori M; Tobita R; Egusa C; Maeda T; Abe N; Kawakami H; Mae K; Matsumoto Y; Kawachi Y; Okubo Y
    J Dermatol; 2021 Nov; 48(11):1745-1753. PubMed ID: 34409641
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Unopposed IL-36 Activity Promotes Clonal CD4
    Arakawa A; Vollmer S; Besgen P; Galinski A; Summer B; Kawakami Y; Wollenberg A; Dornmair K; Spannagl M; Ruzicka T; Thomas P; Prinz JC
    J Invest Dermatol; 2018 Jun; 138(6):1338-1347. PubMed ID: 29288651
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Impetigo herpetiformis with IL36RN mutations in a Chinese patient: A founder haplotype of c.115+6T>C in East Asia.
    Sugiura K; Nakasuka A; Kono H; Kono M; Akiyama M
    J Dermatol Sci; 2015 Sep; 79(3):319-20. PubMed ID: 26104679
    [No Abstract]   [Full Text] [Related]  

  • 74. Identifying patients with deteriorating generalized pustular psoriasis: Development of a prediction model.
    Ohn J; Choi YG; Yun J; Jo SJ
    J Dermatol; 2022 Jul; 49(7):675-681. PubMed ID: 35491617
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Homozygous missense mutation in IL36RN in generalized pustular dermatosis with intraoral involvement compatible with both AGEP and generalized pustular psoriasis.
    Navarini AA; Simpson MA; Borradori L; Yawalkar N; Schlapbach C
    JAMA Dermatol; 2015 Apr; 151(4):452-3. PubMed ID: 25427108
    [No Abstract]   [Full Text] [Related]  

  • 76. Clinical Disease Measures in Generalized Pustular Psoriasis.
    Burden AD; Choon SE; Gottlieb AB; Navarini AA; Warren RB
    Am J Clin Dermatol; 2022 Jan; 23(Suppl 1):39-50. PubMed ID: 35061231
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Mutations in IL36RN in patients with generalized pustular psoriasis.
    Körber A; Mössner R; Renner R; Sticht H; Wilsmann-Theis D; Schulz P; Sticherling M; Traupe H; Hüffmeier U
    J Invest Dermatol; 2013 Nov; 133(11):2634-2637. PubMed ID: 23648549
    [No Abstract]   [Full Text] [Related]  

  • 78. Codeine-induced acute generalized exanthematous pustulosis without IL36RN mutations.
    Chadli Z; Ladhari C; Kerkeni E; Djobbi A; Fredj NB; Chaabane A; Boughattas NA; Aouam K
    Pharmacogenomics; 2018 Jul; 19(11):889-893. PubMed ID: 29914290
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [A case of neonatal-onset generalized pustular psoriasis caused by IL36RN gene variation].
    Zheng L; Jiang SY; Yang L; Cao Y; Chen C; Wang J
    Zhonghua Er Ke Za Zhi; 2022 Aug; 60(8):829-831. PubMed ID: 35922198
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Case of generalized pustular psoriasis with coexisting mutations in IL36RN and CARD14.
    Sawabe Y; Hayashi K; Kamata M; Nagata M; Fukaya S; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Komatsu H; Tanaka M; Sugiura K; Tada Y
    J Dermatol; 2019 Oct; 46(10):e368-e370. PubMed ID: 31062396
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.